To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Technical in-depth comparison of two massive parallel DNA-sequencing methods for formalin-fixed paraffin-embedded tissue from victims of sudden cardiac death
Örebro University, School of Medical Sciences. Department of Laboratory Medicine, Örebro University Hospital, Sweden.ORCID iD: 0000-0002-7954-0696
Örebro University, School of Medical Sciences. Department of Laboratory Medicine, Örebro University Hospital, Sweden.
Division of Drug Research, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden.
Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden.
Show others and affiliations
2021 (English)In: Forensic Science International: Genetics, ISSN 1872-4973, E-ISSN 1878-0326, Vol. 53, article id 102522Article in journal (Refereed) Published
Abstract [en]

Sudden cardiac death (SCD) is a tragic and traumatic event. SCD is often associated with hereditary genetic disease and in such cases, sequencing of stored formalin fixed paraffin embedded (FFPE) tissue is often crucial in trying to find a causal genetic variant. This study was designed to compare two massive parallel sequencing assays for differences in sensitivity and precision regarding variants related to SCD in FFPE material. From eight cases of SCD where DNA from blood had been sequenced using HaloPlex, corresponding FFPE samples were collected six years later. DNA from FFPE samples were amplified using HaloPlex HS, sequenced on MiSeq, representing the first method, as well as amplified using modified Twist and sequenced on NextSeq, representing the second method. Molecular barcodes were included to distinguish artefacts from true variants. In both approaches, read coverage, uniformity and variant detection were compared using genomic DNA isolated from blood and corresponding FFPE tissue, respectively. In terms of coverage uniformity, Twist performed better than HaloPlex HS for FFPE samples. Despite higher overall coverage, amplicon-based HaloPlex technologies, both for blood and FFPE tissue, suffered from design and/or performance issues resulting in genes lacking complete coverage. Although Twist had considerably lower overall mean coverage, high uniformity resulted in equal or higher fraction of genes covered at ≥ 20X. By comparing variants found in the matched samples in a pre-defined cardiodiagnostic gene panel, HaloPlex HS for FFPE material resulted in high sensitivity, 98.0% (range 96.6-100%), and high precision, 99.9% (range 99.5-100%) for moderately fragmented samples, but suffered from reduced sensitivity (range 74.2-91.1%) in more severely fragmented samples due to lack of coverage. Twist had high sensitivity, 97.8% (range 96.8-98.7%) and high precision, 99.9% (range 99.3-100%) in all analyzed samples, including the severely fragmented samples.

Place, publisher, year, edition, pages
Elsevier, 2021. Vol. 53, article id 102522
Keywords [en]
DNA mutational analysis/methods, Death, Sudden, Cardiac, Massive parallel sequencing, MPS, Paraffin embedding, Sequence analysis, DNA, Tissue fixation
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:oru:diva-91666DOI: 10.1016/j.fsigen.2021.102522ISI: 000670126400008PubMedID: 33945952Scopus ID: 2-s2.0-85104938164OAI: oai:DiVA.org:oru-91666DiVA, id: diva2:1553270
Note

Funding Agencies:

ALF funding Region Örebro County  

Örebro County Council Research committee  

Available from: 2021-05-07 Created: 2021-05-07 Last updated: 2026-01-07Bibliographically approved
In thesis
1. Chasing the code: Advancing Precision Diagnostics through Next Generation Sequencing
Open this publication in new window or tab >>Chasing the code: Advancing Precision Diagnostics through Next Generation Sequencing
2026 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Next generation sequencing (NGS) has revolutionized precision diagnostics by enabling high-throughput analysis of nucleic acids. This thesis combines technical validations with innovative applications of NGS across five studies.

Papers I–II focus on molecular autopsies, demonstrating that hybridisation-based whole-exome sequencing can be successfully applied to formalin-fixed paraffin-embedded (FFPE) tissue, even in severely fragmented samples. Using matched blood and FFPE samples, our complete workflow for variant detection achieved a sensitivity of 97% and a positive predictive value of 98%. Applied to clinical cases, 23 of 35 FFPE samples were successfully sequenced, and relevant variants were detected in previously unresolved cases of sudden unexplained death. Paper III expanded forensic analysis on blood using the same hybridisation-based NGS-technology.

Papers IV–V explore liquid biopsy for pan-cancer detection. Using enzymatic conversion and targeted methylation sequencing of plasma circulating cell-free DNA (cfDNA), we identified 162 differentially methylated regions (DMRs) and developed a classifier for pan-cancer detection with sensitivity and specificity of 83.8%. Fragmentomics analysis revealed cancer-associated patterns in cfDNA fragment length and end motifs: cancer samples exhibited shorter median fragment lengths and alterations in fragment end motifs. These findings highlight fragmentomics as a promising biomarker for cancer detection.

Together, these studies illustrate the versatility of NGS for precision diagnostics—from post-mortem genetic analysis to minimally invasive cancer screening—and underscore the importance of rigorous validation to bridge research and clinical implementation.

Place, publisher, year, edition, pages
Örebro: Örebro University, 2026. p. 94
Series
Örebro Studies in Medicine, ISSN 1652-4063 ; 345
Keywords
next generation sequencing, precision diagnostics, genetic testing, sudden death, validation, circulating biomarkers, pan-cancer, methylation markers, fragmentomics
National Category
Other Basic Medicine
Identifiers
urn:nbn:se:oru:diva-124820 (URN)9789175297309 (ISBN)9789175297316 (ISBN)
Public defence
2026-01-30, Örebro universitet, Campus USÖ, hörsal X1, Södra Grev Rosengatan 32, Örebro, 09:00 (Swedish)
Opponent
Supervisors
Available from: 2025-11-06 Created: 2025-11-06 Last updated: 2026-01-09Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Adolfsson, EmmaQvick, AlvidaGreen, Anna

Search in DiVA

By author/editor
Adolfsson, EmmaQvick, AlvidaGreen, Anna
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
Forensic Science International: Genetics
Cardiology and Cardiovascular Disease

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 1179 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf